E-type prostaglandin receptor 4 (EP4) is significantly overexpressed in the PD patients, and researches have suggested that EP4 antagonists can alleviate the progression of PF (Luo et al., 2022). This evidence concerns the gene PTGER4 and pemphigus foliaceus.